InChI=1S/C48H86NO8P/c1- 6- 8- 10- 12- 14- 16- 18- 20- 22- 23- 24- 25- 27- 29- 31- 33- 35- 37- 39- 41- 48(51) 57- 46(45- 56- 58(52,53) 55- 43- 42- 49(3,4) 5) 44- 54- 47(50) 40- 38- 36- 34- 32- 30- 28- 26- 21- 19- 17- 15- 13- 11- 9- 7- 2/h14,16,20- 22,24- 26,29,31,46H,6- 13,15,17- 19,23,27- 28,30,32- 45H2,1- 5H3/b16- 14- ,22- 20- ,25- 24- ,26- 21- ,31- 29- /t46- /m1/s1 |
RNPXVUWNKQBTRY-UXAWILDOSA-N |
CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC |
|
metabolite
Any intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
(via phosphatidylcholine 40:5 )
|
|
View more via ChEBI Ontology
Outgoing
|
1- [(9Z)- octadecenoyl]- 2- [(7Z,10Z,13Z,16Z)- docosatetraenoyl]- sn- glycero- 3- phosphocholine
(CHEBI:86201)
has functional parent
all-cis-docosa-7,10,13,16-tetraenoic acid
(CHEBI:53487)
1- [(9Z)- octadecenoyl]- 2- [(7Z,10Z,13Z,16Z)- docosatetraenoyl]- sn- glycero- 3- phosphocholine
(CHEBI:86201)
has functional parent
oleic acid
(CHEBI:16196)
1- [(9Z)- octadecenoyl]- 2- [(7Z,10Z,13Z,16Z)- docosatetraenoyl]- sn- glycero- 3- phosphocholine
(CHEBI:86201)
is a
phosphatidylcholine 40:5
(CHEBI:64524)
|
|
(2R)- 2- {[(7Z,10Z,13Z,16Z)- docosa- 7,10,13,16- tetraenoyl]oxy}- 3- {[(9Z)- octadec- 9- enoyl]oxy}propyl 2- (trimethylazaniumyl)ethyl phosphate
|
1-Oleoyl-2-adrenoyl-sn-glycero-3-phosphocholine
|
HMDB
|
GPCho(18:1n9/22:4n6)
|
HMDB
|
GPCho(18:1w9/22:4w6)
|
HMDB
|
PC(18:1(9Z)/22:4(7Z,10Z,13Z,16Z))
|
LIPID MAPS
|
PC(18:1n9/22:4n6)
|
HMDB
|
PC(18:1w9/22:4w6)
|
HMDB
|
Phosphatidylcholine(18:1n9/22:4n6)
|
HMDB
|
Phosphatidylcholine(18:1w9/22:4w6)
|
HMDB
|
|